Exploring the Role of Metabolic Hormones in Amyotrophic Lateral Sclerosis
International Journal of Molecular Sciences · 07.05.2024 · 25 (10) · 5059
DOI: 10.3390/ijms25105059 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.05.2024. Verfasst von Anca Moțățăianu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Medicine, Pharmacy, Science and Technology of Târgu Mureș 'George Emil Palade', 540142 Târgu Mureș, Romania. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Islet Amyloid Polypeptide, Biomarkers, Insulin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Research, Innovation and Digitization, CNCS - UEFISCDI, Romania, Ministry of Research, Innovation and Digitization, CNCS-UEFISCDI.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by progressive loss of motor neurons. Emerging evidence suggests a potential link between metabolic dysregulation and ALS pathogenesis. This study aimed to investigate the relationship between metabolic hormones and disease progression in ALS patients. A cross-sectional study was conducted involving 44 ALS patients recruited from a tertiary care center. Serum levels of insulin, total amylin, C-peptide, active ghrelin, GIP (gastric inhibitory peptide), GLP-1 active (glucagon-like peptide-1), glucagon, PYY (peptide YY), PP (pancreatic polypeptide), leptin, interleukin-6, MCP-1 (monocyte chemoattractant protein-1), and TNFα (tumor necrosis factor alpha) were measured, and correlations with ALSFRS-R, evolution scores, and biomarkers were analyzed using Spearman correlation coefficients. Subgroup analyses based on ALS subtypes, progression pattern of disease, and disease progression rate patterns were performed. Significant correlations were observed between metabolic hormones and ALS evolution scores. Insulin and amylin exhibited strong correlations with disease progression and clinical functional outcomes, with insulin showing particularly robust associations. Other hormones such as C-peptide, leptin, and GLP-1 also showed correlations with ALS progression and functional status. Subgroup analyses revealed differences in hormone levels based on sex and disease evolution patterns, with male patients showing higher amylin and glucagon levels. ALS patients with slower disease progression exhibited elevated levels of amylin and insulin. Our findings suggest a potential role for metabolic hormones in modulating ALS progression and functional outcomes. Further research is needed to elucidate the underlying mechanisms and explore the therapeutic implications of targeting metabolic pathways in ALS management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of Medicine, Pharmacy, Science and Technology of Târgu Mureș 'George Emil Palade', 540142 Târgu Mureș, Romania.
- 1st Neurology Clinic, Mures County Clinical Emergency Hospital, 540136 Târgu Mureș, Romania.
- Department of Laboratory Medicine, University of Medicine, Pharmacy, Science and Technology of Târgu Mureș 'George Emil Palade', 540142 Târgu Mureș, Romania.
- Doctoral School, University of Medicine, Pharmacy, Science and Technology of Târgu Mureș 'George Emil Palade', 540142 Târgu Mureș, Romania.
- Faculty of Pharmacy, Department of Analytical Chemistry and Drug Analysis, University of Medicine, Pharmacy, Science and Technology of Târgu Mureș 'George Emil Palade', 540142 Târgu Mureș, Romania.
- Drug Testing Laboratory, University of Medicine, Pharmacy, Science and Technology of Târgu Mureș 'George Emil Palade', 540142 Târgu Mureș, Romania.
ORCID-Profile: Ion Bogdan Mănescu, Georgiana Șerban, Sebastian Andone
Förderung
- Ministry of Research, Innovation and Digitization, CNCS - UEFISCDI, Romania
- Ministry of Research, Innovation and Digitization, CNCS-UEFISCDI
Zitieren
APA
Moțățăianu, A., Mănescu, I. B., Șerban, G., Bărcuțean, L., Ion, V., Bălașa, R., & Andone, S. (2024). Exploring the Role of Metabolic Hormones in Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences, 25(10), 5059. https://doi.org/10.3390/ijms25105059
Vancouver
Moțățăianu A, Mănescu IB, Șerban G, Bărcuțean L, Ion V, Bălașa R, et al. Exploring the Role of Metabolic Hormones in Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences. 2024;25(10):5059. doi:10.3390/ijms25105059
BibTeX
@article{Moianu2024,
author = {Moțățăianu, Anca and Mănescu, Ion Bogdan and Șerban, Georgiana and Bărcuțean, Laura and Ion, Valentin and Bălașa, Rodica and Andone, Sebastian},
title = {Exploring the Role of Metabolic Hormones in Amyotrophic Lateral Sclerosis},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {10},
pages = {5059},
doi = {10.3390/ijms25105059}
}
EUVIMED